Annual report

Period2023-04-01 → 2024-03-31
Filed2025-06-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed

Amends S100TUZY. Amended by S100W5L5 (2025-06-25).

Key figures · 148
MetricValuePeriodScopeSource row
Revenue¥226.7bn2023-04-01 → 2024-03-31Cons.Net sales
Revenue¥228.1bn2022-04-01 → 2023-03-31Cons.Net sales
Revenue¥208.0bn2021-04-01 → 2022-03-31dCons.Net sales (5-year summary)
Revenue¥209.1bn2020-04-01 → 2021-03-31dCons.Net sales (5-year summary)
Revenue¥206.8bn2019-04-01 → 2020-03-31dCons.Net sales (5-year summary)
Operating income¥48.2bn2023-04-01 → 2024-03-31Cons.Operating income
Operating income¥52.3bn2022-04-01 → 2023-03-31Cons.Operating income
Ordinary income¥51.6bn2023-04-01 → 2024-03-31Cons.Ordinary income
Ordinary income¥55.8bn2022-04-01 → 2023-03-31Cons.Ordinary income
Ordinary income¥53.7bn2021-04-01 → 2022-03-31dCons.Ordinary income loss (5-year summary)
Ordinary income¥43.9bn2020-04-01 → 2021-03-31dCons.Ordinary income loss (5-year summary)
Ordinary income¥40.0bn2019-04-01 → 2020-03-31dCons.Ordinary income loss (5-year summary)
Profit before tax¥51.8bn2023-04-01 → 2024-03-31Cons.Income before income taxes
Profit before tax¥56.6bn2022-04-01 → 2023-03-31Cons.Income before income taxes
Net income (owners)¥38.0bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥41.1bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥38.8bn2021-04-01 → 2022-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥33.5bn2020-04-01 → 2021-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥30.8bn2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥38.2bn2023-04-01 → 2024-03-31Cons.Profit loss
Net income¥41.4bn2022-04-01 → 2023-03-31Cons.Profit loss
Total assets¥323.5bnat 2024-03-31Cons.Assets
Total assets¥298.7bnat 2023-03-31Cons.Assets
Total assets¥279.7bnat 2022-03-31dCons.Total assets (5-year summary)
Total assets¥265.5bnat 2021-03-31dCons.Total assets (5-year summary)
Total assets¥249.5bnat 2020-03-31dCons.Total assets (5-year summary)
Total liabilities¥92.6bnat 2024-03-31Cons.Liabilities
Total liabilities¥77.2bnat 2023-03-31Cons.Liabilities
Net assets / equity¥230.9bnat 2024-03-31Cons.Net assets
Net assets / equity¥221.5bnat 2023-03-31Cons.Net assets
Net assets / equity¥208.0bnat 2022-03-31dCons.Net assets
Net assets / equity¥200.6bnat 2021-03-31dCons.Net assets (5-year summary)
Net assets / equity¥185.5bnat 2020-03-31dCons.Net assets (5-year summary)
Cash and deposits¥22.7bnat 2024-03-31Cons.Cash and deposits
Cash and deposits¥29.6bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥22.7bnat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥29.6bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥34.7bnat 2022-03-31dCons.Cash and cash equivalents
Cash & equivalents¥32.4bnat 2021-03-31dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥30.6bnat 2020-03-31dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥33.7bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥35.2bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥41.9bn2021-04-01 → 2022-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥39.9bn2020-04-01 → 2021-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥35.5bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥18.7bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥19.6bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥12.4bn2021-04-01 → 2022-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥12.9bn2020-04-01 → 2021-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥15.6bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥22.1bn2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥25.0bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥27.9bn2021-04-01 → 2022-03-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥25.6bn2020-04-01 → 2021-03-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥25.2bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥272.822023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥291.362022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥271.882021-04-01 → 2022-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥231.732020-04-01 → 2021-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥210.092019-04-01 → 2020-03-31dCons.Basic earnings loss per share (5-year summary)
Net assets per share¥1,641.05at 2024-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥1,557.12at 2023-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥1,454.01at 2022-03-31dCons.Net assets per share (5-year summary)
Net assets per share¥1,384.13at 2021-03-31dCons.Net assets per share (5-year summary)
Net assets per share¥1,264.23at 2020-03-31dCons.Net assets per share (5-year summary)
Equity ratio70.3%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio73.1%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio73.6%at 2022-03-31dCons.Equity to asset ratio (5-year summary)
Equity ratio74.9%at 2021-03-31dCons.Equity to asset ratio (5-year summary)
Equity ratio73.7%at 2020-03-31dCons.Equity to asset ratio (5-year summary)
ROE17.1%2023-04-01 → 2024-03-31Cons.Rate of return on equity (5-year summary)
ROE19.4%2022-04-01 → 2023-03-31Cons.Rate of return on equity (5-year summary)
ROE19.2%2021-04-01 → 2022-03-31dCons.Rate of return on equity (5-year summary)
ROE17.5%2020-04-01 → 2021-03-31dCons.Rate of return on equity (5-year summary)
ROE16.9%2019-04-01 → 2020-03-31dCons.Rate of return on equity (5-year summary)
Employees3,137at 2024-03-31Cons.Number of employees
Employees2,965at 2023-03-31Cons.Number of employees
Employees2,737at 2022-03-31dCons.Number of employees
Employees2,688at 2021-03-31dCons.Number of employees
Employees2,640at 2020-03-31dCons.Number of employees
Revenue¥181.2bn2023-04-01 → 2024-03-31StandaloneNet sales
Revenue¥183.2bn2022-04-01 → 2023-03-31StandaloneNet sales
Revenue¥170.0bn2021-04-01 → 2022-03-31dStandaloneNet sales (5-year summary)
Revenue¥162.5bn2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Revenue¥160.2bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Operating income¥40.9bn2023-04-01 → 2024-03-31StandaloneOperating income
Operating income¥41.8bn2022-04-01 → 2023-03-31StandaloneOperating income
Ordinary income¥45.0bn2023-04-01 → 2024-03-31StandaloneOrdinary income
Ordinary income¥46.4bn2022-04-01 → 2023-03-31StandaloneOrdinary income
Ordinary income¥46.5bn2021-04-01 → 2022-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥39.3bn2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥37.5bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥44.9bn2023-04-01 → 2024-03-31StandaloneIncome before income taxes
Profit before tax¥47.2bn2022-04-01 → 2023-03-31StandaloneIncome before income taxes
Net income¥34.6bn2023-04-01 → 2024-03-31StandaloneProfit loss
Net income¥36.2bn2022-04-01 → 2023-03-31StandaloneProfit loss
Net income¥34.4bn2021-04-01 → 2022-03-31dStandaloneNet income loss (5-year summary)
Net income¥30.7bn2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Net income¥29.6bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Total assets¥257.6bnat 2024-03-31StandaloneAssets
Total assets¥241.8bnat 2023-03-31StandaloneAssets
Total assets¥231.0bnat 2022-03-31dStandaloneTotal assets (5-year summary)
Total assets¥225.6bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total assets¥213.2bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥80.5bnat 2024-03-31StandaloneLiabilities
Total liabilities¥67.1bnat 2023-03-31StandaloneLiabilities
Net assets / equity¥177.0bnat 2024-03-31StandaloneNet assets
Net assets / equity¥174.7bnat 2023-03-31StandaloneNet assets
Net assets / equity¥168.4bnat 2022-03-31dStandaloneNet assets
Net assets / equity¥165.6bnat 2021-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥155.4bnat 2020-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥14.5bnat 2024-03-31StandaloneCash and deposits
Cash and deposits¥21.7bnat 2023-03-31StandaloneCash and deposits
EPS (basic)¥2482023-04-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥256.492022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥241.212021-04-01 → 2022-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥212.522020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥201.762019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥1642023-04-01 → 2024-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1642022-04-01 → 2023-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1222021-04-01 → 2022-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥1042020-04-01 → 2021-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥902019-04-01 → 2020-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥1,277.1at 2024-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,245.72at 2023-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,188.84at 2022-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,152.93at 2021-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,068.43at 2020-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio68.7%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio72.3%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio72.9%at 2022-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio73.4%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio72.9%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE19.7%2023-04-01 → 2024-03-31StandaloneRate of return on equity (5-year summary)
ROE21.1%2022-04-01 → 2023-03-31StandaloneRate of return on equity (5-year summary)
ROE20.6%2021-04-01 → 2022-03-31dStandaloneRate of return on equity (5-year summary)
ROE19.1%2020-04-01 → 2021-03-31dStandaloneRate of return on equity (5-year summary)
ROE19.2%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued138,800,000at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued141,300,000at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued143,000,000at 2022-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued145,000,000at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued146,000,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees2,011at 2024-03-31StandaloneNumber of employees
Employees1,959at 2023-03-31StandaloneNumber of employees
Employees1,929at 2022-03-31dStandaloneNumber of employees
Employees1,924at 2021-03-31dStandaloneNumber of employees
Employees1,890at 2020-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 122
SegmentItemPeriodValue
Otherother segmentscapex2023-04-01 → 2024-03-31¥1.8bn
Otherother segmentsdepreciation2023-04-01 → 2024-03-31¥748m
Otherother segmentsemployeesat 2024-03-31482 pure
Otherother segmentsrevenue2023-04-01 → 2024-03-31¥30.2bn
Otherother segmentsrevenue external2023-04-01 → 2024-03-31¥11.2bn
Otherother segmentsrevenue intersegment2023-04-01 → 2024-03-31¥19.0bn
Otherother segmentssegment assetsat 2024-03-31¥21.1bn
Otherother segmentssegment profit2023-04-01 → 2024-03-31¥572m
Reconciling Itemsreconcilingcapex2023-04-01 → 2024-03-31¥468m
Reconciling Itemsreconcilingdepreciation2023-04-01 → 2024-03-31¥471m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2024-03-31−¥115.8bn
Reconciling Itemsreconcilingrevenue external2023-04-01 → 2024-03-31−¥27.1bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2024-03-31−¥88.7bn
Reconciling Itemsreconcilingsegment assetsat 2024-03-31¥30.4bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2024-03-31−¥4.9bn
Agrochemicalsreportable segmentcapex2023-04-01 → 2024-03-31¥6.8bn
Agrochemicalsreportable segmentdepreciation2023-04-01 → 2024-03-31¥3.3bn
Agrochemicalsreportable segmentemployeesat 2024-03-31710 pure
Agrochemicalsreportable segmentrevenue2023-04-01 → 2024-03-31¥82.1bn
Agrochemicalsreportable segmentrevenue external2023-04-01 → 2024-03-31¥67.4bn
Agrochemicalsreportable segmentrevenue intersegment2023-04-01 → 2024-03-31¥14.7bn
Agrochemicalsreportable segmentsegment assetsat 2024-03-31¥119.5bn
Agrochemicalsreportable segmentsegment profit2023-04-01 → 2024-03-31¥23.4bn
Chemicalsreportable segmentcapex2023-04-01 → 2024-03-31¥4.2bn
Chemicalsreportable segmentdepreciation2023-04-01 → 2024-03-31¥2.7bn
Chemicalsreportable segmentemployeesat 2024-03-31380 pure
Chemicalsreportable segmentrevenue2023-04-01 → 2024-03-31¥35.6bn
Chemicalsreportable segmentrevenue external2023-04-01 → 2024-03-31¥23.5bn
Chemicalsreportable segmentrevenue intersegment2023-04-01 → 2024-03-31¥12.1bn
Chemicalsreportable segmentsegment assetsat 2024-03-31¥33.2bn
Chemicalsreportable segmentsegment profit2023-04-01 → 2024-03-31¥48m
Medicinesreportable segmentcapex2023-04-01 → 2024-03-31¥473m
Medicinesreportable segmentdepreciation2023-04-01 → 2024-03-31¥367m
Medicinesreportable segmentemployeesat 2024-03-31105 pure
Medicinesreportable segmentrevenue2023-04-01 → 2024-03-31¥6.3bn
Medicinesreportable segmentrevenue external2023-04-01 → 2024-03-31¥6.2bn
Medicinesreportable segmentrevenue intersegment2023-04-01 → 2024-03-31¥71m
Medicinesreportable segmentsegment assetsat 2024-03-31¥8.6bn
Medicinesreportable segmentsegment profit2023-04-01 → 2024-03-31¥2.8bn
Performance Materialsreportable segmentcapex2023-04-01 → 2024-03-31¥9.4bn
Performance Materialsreportable segmentdepreciation2023-04-01 → 2024-03-31¥6.0bn
Performance Materialsreportable segmentemployeesat 2024-03-31888 pure
Performance Materialsreportable segmentrevenue2023-04-01 → 2024-03-31¥84.6bn
Performance Materialsreportable segmentrevenue external2023-04-01 → 2024-03-31¥67.2bn
Performance Materialsreportable segmentrevenue intersegment2023-04-01 → 2024-03-31¥17.4bn
Performance Materialsreportable segmentsegment assetsat 2024-03-31¥70.6bn
Performance Materialsreportable segmentsegment profit2023-04-01 → 2024-03-31¥22.5bn
Tradingreportable segmentcapex2023-04-01 → 2024-03-31¥39m
Tradingreportable segmentdepreciation2023-04-01 → 2024-03-31¥77m
Tradingreportable segmentemployeesat 2024-03-31203 pure
Tradingreportable segmentrevenue2023-04-01 → 2024-03-31¥103.8bn
Tradingreportable segmentrevenue external2023-04-01 → 2024-03-31¥78.3bn
Tradingreportable segmentrevenue intersegment2023-04-01 → 2024-03-31¥25.5bn
Tradingreportable segmentsegment assetsat 2024-03-31¥40.0bn
Tradingreportable segmentsegment profit2023-04-01 → 2024-03-31¥3.7bn
—segment totalcapex2023-04-01 → 2024-03-31¥22.7bn
—segment totaldepreciation2023-04-01 → 2024-03-31¥13.2bn
—segment totalrevenue2023-04-01 → 2024-03-31¥342.5bn
—segment totalrevenue external2023-04-01 → 2024-03-31¥253.8bn
—segment totalrevenue intersegment2023-04-01 → 2024-03-31¥88.7bn
—segment totalsegment assetsat 2024-03-31¥293.0bn
—segment totalsegment profit2023-04-01 → 2024-03-31¥53.1bn
Otherother segmentscapex2022-04-01 → 2023-03-31¥366m
Otherother segmentsdepreciation2022-04-01 → 2023-03-31¥442m
Otherother segmentsrevenue2022-04-01 → 2023-03-31¥26.4bn
Otherother segmentsrevenue external2022-04-01 → 2023-03-31¥12.1bn
Otherother segmentsrevenue intersegment2022-04-01 → 2023-03-31¥14.3bn
Otherother segmentssegment assetsat 2023-03-31¥13.6bn
Otherother segmentssegment profit2022-04-01 → 2023-03-31¥879m
Reconciling Itemsreconcilingcapex2022-04-01 → 2023-03-31¥787m
Reconciling Itemsreconcilingdepreciation2022-04-01 → 2023-03-31¥249m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2023-03-31−¥107.3bn
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2023-03-31−¥29.2bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2023-03-31−¥78.1bn
Reconciling Itemsreconcilingsegment assetsat 2023-03-31¥41.1bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2023-03-31−¥5.2bn
Agrochemicalsreportable segmentcapex2022-04-01 → 2023-03-31¥6.2bn
Agrochemicalsreportable segmentdepreciation2022-04-01 → 2023-03-31¥2.7bn
Agrochemicalsreportable segmentrevenue2022-04-01 → 2023-03-31¥81.6bn
Agrochemicalsreportable segmentrevenue external2022-04-01 → 2023-03-31¥70.3bn
Agrochemicalsreportable segmentrevenue intersegment2022-04-01 → 2023-03-31¥11.3bn
Agrochemicalsreportable segmentsegment assetsat 2023-03-31¥104.0bn
Agrochemicalsreportable segmentsegment profit2022-04-01 → 2023-03-31¥23.1bn
Chemicalsreportable segmentcapex2022-04-01 → 2023-03-31¥3.7bn
Chemicalsreportable segmentdepreciation2022-04-01 → 2023-03-31¥2.5bn
Chemicalsreportable segmentrevenue2022-04-01 → 2023-03-31¥39.0bn
Chemicalsreportable segmentrevenue external2022-04-01 → 2023-03-31¥26.5bn
Chemicalsreportable segmentrevenue intersegment2022-04-01 → 2023-03-31¥12.5bn
Chemicalsreportable segmentsegment assetsat 2023-03-31¥34.2bn
Chemicalsreportable segmentsegment profit2022-04-01 → 2023-03-31¥1.4bn
Medicinesreportable segmentcapex2022-04-01 → 2023-03-31¥449m
Medicinesreportable segmentdepreciation2022-04-01 → 2023-03-31¥376m
Medicinesreportable segmentrevenue2022-04-01 → 2023-03-31¥6.7bn
Medicinesreportable segmentrevenue external2022-04-01 → 2023-03-31¥6.7bn
Medicinesreportable segmentrevenue intersegment2022-04-01 → 2023-03-31¥11m
Medicinesreportable segmentsegment assetsat 2023-03-31¥7.7bn
Medicinesreportable segmentsegment profit2022-04-01 → 2023-03-31¥3.0bn
Performance Materialsreportable segmentcapex2022-04-01 → 2023-03-31¥8.7bn
Performance Materialsreportable segmentdepreciation2022-04-01 → 2023-03-31¥4.6bn
Performance Materialsreportable segmentrevenue2022-04-01 → 2023-03-31¥82.6bn
Performance Materialsreportable segmentrevenue external2022-04-01 → 2023-03-31¥66.2bn
Performance Materialsreportable segmentrevenue intersegment2022-04-01 → 2023-03-31¥16.4bn
Performance Materialsreportable segmentsegment assetsat 2023-03-31¥61.3bn
Performance Materialsreportable segmentsegment profit2022-04-01 → 2023-03-31¥25.4bn
Tradingreportable segmentcapex2022-04-01 → 2023-03-31¥66m
Tradingreportable segmentdepreciation2022-04-01 → 2023-03-31¥65m
Tradingreportable segmentrevenue2022-04-01 → 2023-03-31¥99.1bn
Tradingreportable segmentrevenue external2022-04-01 → 2023-03-31¥75.5bn
Tradingreportable segmentrevenue intersegment2022-04-01 → 2023-03-31¥23.5bn
Tradingreportable segmentsegment assetsat 2023-03-31¥36.8bn
Tradingreportable segmentsegment profit2022-04-01 → 2023-03-31¥3.7bn
—segment totalcapex2022-04-01 → 2023-03-31¥19.5bn
—segment totaldepreciation2022-04-01 → 2023-03-31¥10.6bn
—segment totalrevenue2022-04-01 → 2023-03-31¥335.4bn
—segment totalrevenue external2022-04-01 → 2023-03-31¥257.2bn
—segment totalrevenue intersegment2022-04-01 → 2023-03-31¥78.1bn
—segment totalsegment assetsat 2023-03-31¥257.6bn
—segment totalsegment profit2022-04-01 → 2023-03-31¥57.5bn
Agrochemicalsreportable segmentemployeesat 2024-03-31550 pure
Chemicalsreportable segmentemployeesat 2024-03-31380 pure
Medicinesreportable segmentemployeesat 2024-03-31105 pure
Performance Materialsreportable segmentemployeesat 2024-03-31607 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,860
ItemContextValueUnit
Cost of salesCurrentYearDuration121930000000JPY
Gross profitPrior1YearDuration106803000000JPY
Gross profitCurrentYearDuration104774000000JPY
Selling general and administrative expensesPrior1YearDuration54519000000JPY
Selling general and administrative expensesCurrentYearDuration56572000000JPY
Operating incomePrior1YearDuration52283000000JPY
Operating incomeCurrentYearDuration48201000000JPY
Interest income noiPrior1YearDuration203000000JPY
Interest income noiCurrentYearDuration161000000JPY
Dividends income noiPrior1YearDuration1323000000JPY
Dividends income noiCurrentYearDuration1560000000JPY
Equity in earnings of affiliates noiPrior1YearDuration1485000000JPY
Equity in earnings of affiliates noiCurrentYearDuration536000000JPY
Foreign exchange gains noiPrior1YearDuration1296000000JPY
Foreign exchange gains noiCurrentYearDuration2210000000JPY
Other noiPrior1YearDuration694000000JPY
Other noiCurrentYearDuration810000000JPY
Non operating incomePrior1YearDuration5004000000JPY
Non operating incomeCurrentYearDuration5280000000JPY
Interest expenses noePrior1YearDuration252000000JPY
Interest expenses noeCurrentYearDuration526000000JPY
Loss on disposal of noncurrent assets noePrior1YearDuration817000000JPY
Loss on disposal of noncurrent assets noeCurrentYearDuration935000000JPY
Loss on sales of noncurrent assets noePrior1YearDuration5000000JPY
Loss on sales of noncurrent assets noeCurrentYearDuration10000000JPY
Plant stop loss noePrior1YearDuration198000000JPY
Plant stop loss noeCurrentYearDuration169000000JPY
Other noePrior1YearDuration220000000JPY
Other noeCurrentYearDuration211000000JPY
Non operating expensesPrior1YearDuration1493000000JPY
Non operating expensesCurrentYearDuration1853000000JPY
Ordinary incomePrior1YearDuration55793000000JPY
Ordinary incomeCurrentYearDuration51629000000JPY
Gain on sales of investment securities eiPrior1YearDuration1461000000JPY
Gain on sales of investment securities eiCurrentYearDuration1332000000JPY
Extraordinary incomePrior1YearDuration1461000000JPY
Extraordinary incomeCurrentYearDuration1332000000JPY
Impairment loss elPrior1YearDuration-JPY
Impairment loss elCurrentYearDuration823000000JPY
Loss on valuation of investment securities elPrior1YearDuration650000000JPY
Loss on valuation of investment securities elCurrentYearDuration353000000JPY
Extraordinary lossPrior1YearDuration650000000JPY
Extraordinary lossCurrentYearDuration1176000000JPY
Income before income taxesPrior1YearDuration56605000000JPY
Income before income taxesCurrentYearDuration51785000000JPY
Income taxes currentPrior1YearDuration14554000000JPY
Income taxes currentCurrentYearDuration12847000000JPY
Income taxes deferredPrior1YearDuration633000000JPY
Income taxes deferredCurrentYearDuration730000000JPY
Income taxesPrior1YearDuration15187000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identitynon_consolidated 2023-03-31pass rounding
balance sheet identitynon_consolidated 2024-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2024-03-31pass
statement vs summary · revenueconsolidated 2022-04-01/2023-03-31pass
statement vs summary · revenueconsolidated 2023-04-01/2024-03-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass